Article (Published version) (496 Kb) - 
Limited access to UNIGE
Highlights
More informations
Scientific Article - Review
unige:45062 
 |
Hormone de croissance et carcinogenèse: le point sur la question |
|
| Authors | ||
| Published in | Revue médicale de la Suisse romande. 2003, vol. 123, no. 6, p. 397-400 | |
| Abstract | Over the past 20 years, the use of recombinant growth hormone (rhGH) has become more frequent and the indications for this therapy extended to more common conditions than primary pituitary dysfunction. GH, a very strong anabolic agent, alters body growth and composition, and metabolic pathways. RhGH therapy seems to be beneficial in certain types of pathologies and surgical procedures, by preventing the deleterious effects due to catabolism and by increasing immune function, healing process and muscular strength. Several types of tumors have been studied to investigate the rhGH-related oncological risks. This article aims at reviewing the clinical studies focused on the possible association between rhGH and cancer. | |
| Keywords | Growth Hormone/adverse effects/physiology — Humans — Neoplasms/etiology | |
| Identifiers | PMID: 15095681 | |
| Full text | ||
| Structures | ||
| Research groups | Chirurgie viscérale (104) Nutrition clinique (597) Groupe Giacobino Ariane (génétique) (923) | |
| Citation (ISO format) | GOTTRAUX, Sophie Aline et al. Hormone de croissance et carcinogenèse: le point sur la question. In: Revue médicale de la Suisse romande, 2003, vol. 123, n° 6, p. 397-400. https://archive-ouverte.unige.ch/unige:45062 |
138 hits 
0 download 
Contact an author
Update